Cargando…
Demethylating Agents in the Treatment of Cancer
Gene silencing resulting from aberrant DNA methylation can lead to tumorigenesis. Therefore, drugs that inhibit or interfere with DNA methylation have been used to reactivate and induce silenced gene re-expression in malignancies. Two demethylating agents, azacitidine and decitabine, are approved fo...
Autores principales: | Howell, Paul M., Liu, Zixing, Khong, Hung T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036667/ https://www.ncbi.nlm.nih.gov/pubmed/27713340 http://dx.doi.org/10.3390/ph3072022 |
Ejemplares similares
-
Therapeutic Applications of Azanucleoside Analogs as DNA Demethylating Agents
por: Gallimore, Fallon, et al.
Publicado: (2023) -
Protein arginine methylation/demethylation and cancer
por: Poulard, Coralie, et al.
Publicado: (2016) -
TET proteins and the control of cytosine demethylation in cancer
por: Scourzic, Laurianne, et al.
Publicado: (2015) -
Active DNA Demethylation in Plants
por: Parrilla-Doblas, Jara Teresa, et al.
Publicado: (2019) -
DNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire
por: Nie, Jing, et al.
Publicado: (2016)